Role of Mitochondria in Methamphetamine-Induced Dopaminergic Neurotoxicity: Involvement in Oxidative Stress, Neuroinflammation, and Pro-apoptosis—A Review

被引:0
作者
Eun-Joo Shin
Hai-Quyen Tran
Phuong-Tram Nguyen
Ji Hoon Jeong
Seung-Yeol Nah
Choon-Gon Jang
Toshitaka Nabeshima
Hyoung-Chun Kim
机构
[1] Kangwon National University,Neuropsychopharmacology and Toxicology Program, College of Pharmacy
[2] Chung-Ang University,Department of Pharmacology, College of Medicine
[3] Konkuk University,Ginsentology Research Laboratory and Department of Physiology, College of Veterinary Medicine
[4] Sungkyunkwan University,Department of Pharmacology, School of Pharmacy
[5] Fujita Health University Graduate School of Health Science,Advanced Diagnostic System Research Laboratory
来源
Neurochemical Research | 2018年 / 43卷
关键词
Methamphetamine; Dopaminergic toxicity; Mitochondria; Apoptosis; Protein kinase Cδ;
D O I
暂无
中图分类号
学科分类号
摘要
Methamphetamine (MA), an amphetamine-type psychostimulant, is associated with dopaminergic toxicity and has a high abuse potential. Numerous in vivo and in vitro studies have suggested that impaired mitochondria are critical in dopaminergic toxicity induced by MA. Mitochondria are important energy-producing organelles with dynamic nature. Evidence indicated that exposure to MA can disturb mitochondrial energetic metabolism by inhibiting the Krebs cycle and electron transport chain. Alterations in mitochondrial dynamic processes, including mitochondrial biogenesis, mitophagy, and fusion/fission, have recently been shown to contribute to dopaminergic toxicity induced by MA. Furthermore, it was demonstrated that MA-induced mitochondrial impairment enhances susceptibility to oxidative stress, pro-apoptosis, and neuroinflammation in a positive feedback loop. Protein kinase Cδ has emerged as a potential mediator between mitochondrial impairment and oxidative stress, pro-apoptosis, or neuroinflammation in MA neurotoxicity. Understanding the role and underlying mechanism of mitochondrial impairment could provide a molecular target to prevent or alleviate dopaminergic toxicity induced by MA.
引用
收藏
页码:66 / 78
页数:12
相关论文
共 913 条
[1]  
Nordahl TE(2003)Neuropsychological effects of chronic methamphetamine use on neurotransmitters and cognition: a review J Neuropsychiatry Clin Neurosci 15 317-325
[2]  
Salo R(2002)Persistent antagonism of methamphetamine-induced dopamine release in rats pretreated with GBR12909 decanoate J Pharmacol Exp Ther 301 1190-1197
[3]  
Leamon M(1983)Alpha-methyltyrosine attenuates and reserpine increases METH-induced neuronal changes Brain Res 270 285-288
[4]  
Baumann MH(1999)Increased methamphetamine neurotoxicity in heterozygous vesicular monoamine transporter 2 knock-out mice J Neurosci 19 2424-2431
[5]  
Ayestas MA(2008)Reduced vesicular storage of dopamine exacerbates methamphetamine-induced neurodegeneration and astrogliosis J Neurochem 106 2205-2217
[6]  
Sharpe LG(2005)Mechanisms of neurotransmitter release by amphetamines: a review Prog Neurobiol 75 406-433
[7]  
Lewis DB(2013)Methamphetamine use: a comprehensive review of molecular, preclinical and clinical findings Drug Alcohol Depend 129 167-179
[8]  
Rice KC(1980)Short-term and long-term effects of methamphetamine on biogenic amine metabolism in extra-striatal dopaminergic nuclei Neuropharmacology 19 989-995
[9]  
Rothman RB(1992)Striatal subregions are differentially vulnerable to the neurotoxic effects of methamphetamine Brain Res 598 321-326
[10]  
Wagner GC(1997)Decreases in evoked overflow of dopamine in rat striatum after neurotoxic doses of methamphetamine J Pharmacol Exp Ther 280 105-113